Trial site
Dkc Fokus-5 Lzip OOD
- 35running trials
- 16closed trials
The trials here
What the 51 trials at this site are about, from their registry records.
- Conditions
- Hidradenitis suppurativa13 trials
- Psoriatic arthritis8 trials
- Atopic dermatitis (eczema)7 trials
- Lupus (SLE)7 trials
- Psoriasis7 trials
- Dermatomyositis and polymyositis (myositis)3 trials
- Vitiligo3 trials
- Chronic spontaneous urticaria2 trials
- Rheumatoid arthritis2 trials
- Ulcerative colitis2 trials
- Alopecia areata1 trial
- Ankylosing spondylitis1 trial
- and 2 more
- Phase
- Phase 335 trials
- Phase 212 trials
- Phase 2/34 trials
- Status
- Active, not recruiting21 trials
- Completed16 trials
- Recruiting9 trials
- Not yet recruiting5 trials
- Lead sponsor
- AbbVie7 trials
- MoonLake Immunotherapeutics AG5 trials
- Incyte Corporation4 trials
- Pfizer4 trials
- Takeda4 trials
- and 24 more
Running trials
Not yet recruiting
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa
Recruiting
Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Not yet recruiting
Recruiting
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Recruiting
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Active, not recruiting
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
Active, not recruiting
Enrolling by invitation
Active, not recruiting
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hidradenitis suppurativa3 recruiting
- Atopic dermatitis (eczema)2 recruiting
- Dermatomyositis and polymyositis (myositis)2 recruiting
- Lupus (SLE)2 recruiting
- Psoriatic arthritis2 recruiting
- Ulcerative colitis2 recruiting
- Chronic spontaneous urticaria1 recruiting
- Psoriasis1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
A study to test if izokibep improves psoriatic arthritis symptoms and to see how safe izokibep is
Completed
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Completed
Completed
Completed
Completed
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026